Insider · CIK 0001415537
Mark T Iwicki
ceoofficerdirector
Files at KALA (KALA BIO, Inc.), MRUS (Merus N.V.), QTTB (Q32 Bio Inc.), AKRO (Akero Therapeutics, Inc.), IKT (Inhibikase Therapeutics, Inc.), THRD (Third Harmonic Bio, Inc.). First filing Jan 7, 2025, latest Jun 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $178k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KALA: KALA BIO, Inc.
KALAOct 9, 2026 · close 0.29
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | KALA BIO, Inc. | $53k 13,227 shares | -5% | +36% from low-64% from high | |
| 16Weak | KALA BIO, Inc. | $41k 10,866 shares | -4% | +39% from low-63% from high | |
| 16Weak | KALA BIO, Inc. | $41k 10,866 shares | -4% | +39% from low-63% from high | |
| 26Weak | KALA BIO, Inc. | $44k 5,779 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Common Stock | -9,398 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -26,000 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,000 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,000 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -13,000 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -13,000 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,587 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,493 | - | - | 0 | Dec 9, 2025 |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -76,227 | - | - | 0 | Dec 9, 2025 |
| Aug 11, 2025 | THRD Third Harmonic Bio, Inc. | JOther Common Stock | -128,631 | - | - | 0 | Aug 14, 2025 |
| Aug 11, 2025 | THRD Third Harmonic Bio, Inc. | JOther Stock Optionderivative | -83,296 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Feb 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +602,346 | $0.00 | $0 | 602,346 | Jul 2, 2025 |
| Jun 24, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -13,227 | $4.01 | $53k | 258,433 | Jun 26, 2025 |
| Jun 15, 2025 | KALA KALA BIO, Inc. | AGrant or award Common Stock | +2,450 | $0.00 | $0 | 271,660 | Jun 17, 2025 |
| Jun 15, 2025 | KALA KALA BIO, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,450 | $0.00 | $0 | 5,450 | Jun 17, 2025 |
| Jun 3, 2025 | AKRO Akero Therapeutics, Inc. | AGrant or award Common Stock | +9,398 | $0.00 | $0 | 9,398 | Jun 5, 2025 |
| Jun 3, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -10,866 | $3.74 | $41k | 269,210 | Jun 5, 2025 |
| Jun 3, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | +10,866 | $3.74 | $41k | 269,210 | Jun 4, 2025 |
| May 22, 2025 | MRUS Merus N.V. | AGrant or award Share Option (right to buy)derivative | +13,193 | $0.00 | $0 | 13,193 | May 27, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -37,222 | $0.00 | $0 | 0 | Feb 26, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +37,222 | $0.00 | $0 | 37,222 | Feb 26, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,615 | $0.00 | $0 | 0 | Feb 26, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +7,615 | $0.00 | $0 | 7,615 | Feb 26, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,534 | $0.00 | $0 | 0 | Feb 26, 2025 |
| Feb 24, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,534 | $0.00 | $0 | 25,534 | Feb 26, 2025 |
| Feb 21, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +602,346 | $0.00 | $0 | 602,346 | Feb 25, 2025 |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +4,373,857 | $0.00 | $0 | 4,373,857 | Feb 19, 2025 |
| Feb 17, 2025 | IKT Inhibikase Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,794,291 | $0.00 | $0 | 1,794,291 | Feb 19, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | AGrant or award Common Stock | +22,100 | $0.00 | $0 | 285,855 | Jan 7, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -5,779 | $7.63 | $44k | 280,076 | Jan 7, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | AGrant or award Stock Option (right to buy)derivative | +99,500 | $0.00 | $0 | 99,500 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.